Catalyst Wire Dossier Catalyst Wire Dossier

SUN101

EP-101 · Sunovion Respiratory Development Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SUN101, covering 2018-03-08 to 2018-05-07. Get the full timeline:

Most recent: Clinical Trial Update: Study to Investigate the Dose Response, Safety and Efficacy of Nebulized EP-101(SUN101) in Patients With Chronic Obstructive Pulmonary Disease (COPD): GOLDEN-1 Study [Phase 2]

See pricing